Pubdate: Mon, 17 Nov 2003
Source: Los Angeles Times (CA)
Section: The State
Copyright: 2003 Los Angeles Times
Contact:  http://www.latimes.com/
Details: http://www.mapinc.org/media/248
Author: Daniel Costello
Bookmark: http://www.mapinc.org/hr.htm (Harm Reduction)
Bookmark: http://www.mapinc.org/find?132 (Heroin Overdose)

ANTI-OVERDOSE DRUG GIVEN TO S.F. ADDICTS

For The First Time In The State, A Public Agency Is Providing Naloxone. 
Critics Say Treatment Programs Are A Better Approach.

Marking a first for a public agency in California, the San Francisco health 
department began dispensing a controversial anti-overdose medication to 
heroin addicts Saturday at a city-sponsored needle exchange program.

Despite criticism that it could encourage further addiction, San Francisco 
health officials say their plan to distribute the prescription medicine, 
known as naloxone, will save lives and possibly give addicts a chance to 
eventually go clean.

A mix of health department staff and volunteers trained 11 drug users in a 
Tenderloin-area clinic. Officials hope to expand that number substantially 
over the next few weeks.

"We know this saves lives and has almost no side effects. It's a miracle 
drug," said Dr. Josh Bamberger, who oversees the new program at the city 
Department of Public Health.

A few other public agencies around the country have taken similar steps. In 
California, a private, nonprofit health group in Mendocino County two 
months ago began offering naloxone to a small group of clients.

But officials say San Francisco is the first public agency in the state to 
distribute the medicine.

The step is part of a 3-year-old initiative that seeks to reduce the 
harmful effects of drug use in San Francisco rather than solely trying to 
keep addicts from taking drugs. Other efforts include methadone treatments, 
needle-exchange programs to reduce the transmission of diseases and medical 
attention for complications from addiction, such as skin infections.

The naloxone program requires people who receive the drug to be trained in 
how to administer it and how to perform other rescue techniques to assist 
overdose victims. The medicine is injected into an arm or leg and doctors 
say victims can recover in a matter of minutes. It is mainly used with 
heroin overdoses but is also effective with other opiates such as morphine 
and Oxycontin. Each addict in the training program this weekend received 
two syringes pre-filled with naloxone.

Officials describe naloxone as a nonaddictive, non-mood-altering drug that 
doctors and paramedics have used to treat victims of opiate overdose for 
decades. The medication has no street value and the common generic version 
costs as little as a dollar a dose.

The drug works by blocking opioid receptor sites in the brain.

Critics, including some physicians, worry that dispensing naloxone to 
addicts may cause more harm than good. Some fear addicts may not call 
paramedics after they revive a friend, while others are concerned that 
public funding of such a program endorses addiction.

"This is a huge mistake," says Dr. Eric Voth, a Kansas addiction specialist 
and spokesman for Drug Free America, a national group that targets drug 
abuse. "It just isn't safe to remove this from a medical setting and put it 
in the hands of addicts who are notoriously unreliable," he says.

Voth adds he would rather see the money spent on treatment programs so 
addicts could get off the drugs.

Health officials in Portland, Maine, scrapped plans to distribute overdose 
medication to heroin users last year after intense public pressure.

Doctors say there is a possibility, although rare, that someone recovering 
from an overdose after being treated with naloxone may experience a 
dangerous seizure.

And for those addicted to opiates, naloxone immediately pushes them into an 
agonizing withdrawal that often produces nausea, tremors and extreme 
sweats. Because of the discomfort, some addicts may want to shoot up again 
quickly, possibly setting themselves up for another overdose, critics say.

Peter Warren, a spokesman for the California Medical Assn., says the 
organization agrees with efforts to reduce the harmful effects of addiction 
but is wary of any initiative that doesn't include efforts to get addicts 
into treatment and counseling.

Many naloxone programs encourage users to enter such programs but don't 
require it.

Last year, a six-month study by researchers at UC San Francisco, partially 
funded by the city Department of Public Health, tracked 24 addicts who were 
given naloxone, along with eight hours of training, latex gloves and 
alcohol swabs. In all, participants reported witnessing 20 overdoses and 
successfully used the medication on 14 occasions.

For various reasons, the other six overdose victims were not given naloxone 
but survived.

Alex Kral, director of Urban Health Studies at UC San Francisco and an 
author of the study, says that a large publicly funded naloxone program in 
San Francisco is needed and viable. He points out that groups in San 
Francisco have been providing naloxone underground for several years.

"I think the medical establishment is slowly coming around to this and 
seeing it as a solution to a needless problem," he says.

New Mexico currently is dispensing the drug in several locations throughout 
the state and both Baltimore and New York City are planning to start 
similar programs in the next few months. Some private doctors and 
community-based organizations have also recently started providing the 
medication. (Los Angeles health officials say they have no plans to 
distribute naloxone.)

New Mexico and Connecticut have passed laws limiting liability for 
nonmedical people who administer naloxone, including law enforcement 
officers or friends who are trying to save an addict. In San Francisco, 
doctors say they don't need a liability law because they are prescribing a 
legal medication and are covered by patient-client relationship.

But a friend who administers the drug to an addict could be held liable for 
any ill effects.

Nationally, heroin use is climbing dramatically, aided by a plunge in the 
drug's price.

The number of new heroin users during the last decade grew by more than 
100,000 per year - a pace not seen since the early 1970s. It's estimated 
that 2% of all heroin addicts die each year.

Although overdose deaths in San Francisco have eased in recent years, the 
city averages more than 120 annually. That often surpasses the city's 
homicide numbers.

Health officials say that people who have gone through drug treatment and 
fall back into their old habits are at particularly high risk of overdose. 
They often don't decrease the amount of drug they use to match their newer, 
lower tolerance to the drug. That's why some programs around the country 
are dispensing the anti-overdose medication to addicts leaving jail after 
short terms.

Contrary to popular belief, many addicts who overdose on opiates survive 
for up to an hour. That leaves a large window of time to treat an overdose 
victim, including the use of naloxone, doctors say.

Research shows that most people overdose near someone else and that up to 
three quarters of all addicts don't call paramedics if a friend is overdosing.

Dr. Karl Sporer, an emergency physician at San Francisco General Hospital, 
says many addicts instead rely on a slew of popular street remedies that 
are believed to revive overdose victims, like filling their pants with ice 
or injecting them with milk.

Because the idea of dispensing naloxone to addicts is relatively new, there 
is little research proving the programs reduce mortality rates. 
Anecdotally, officials in New Mexico and Chicago say they've seen up to a 
20% drop in overdose cases since they've started distributing naloxone.

Bamberger, the San Francisco health official, expects that his department 
will train up to 600 users over the next year. Addicts interested in 
receiving naloxone must first go through an hourlong training on how to 
administer the drug as well as how to provide rescue breathing and other 
life-saving techniques.
- ---
MAP posted-by: Beth Wehrman